| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Benchmark analyst David Williams reiterates MaxLinear (NASDAQ:MXL) with a Buy and maintains $25 price target.
MaxLinear (NASDAQ:MXL) sees Q4 sales of $130.000 million-$140.000 million vs $130.017 million analyst estimate.
MaxLinear (NASDAQ:MXL) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.12 by 17....
Benchmark analyst David Williams reiterates MaxLinear (NASDAQ:MXL) with a Buy and maintains $25 price target.